When was Qiagen founded?

Qiagen was founded in 1984 and raised its 1st funding round 23 years after it was founded.

Where is Qiagen located?

Qiagen is headquartered in Venlo, Netherlands.

Who is the current CEO of Qiagen?

Metin Colpan of Qiagen. They have also founded 1 company.

Which legal entities is Qiagen associated with?

Qiagen is associated with QIAGEN NEW ZEALAND LIMITED and 4 others.

How many employees does Qiagen have?

As of Mar 31, 2026, the latest employee count at Qiagen is 5539.

Is Qiagen a funded company?

Qiagen is a funded company, having raised an undisclosed amount across 13 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Oct 02, 2007.

When was the latest funding round of Qiagen?

Qiagen's latest funding was a $***** Grant (prize money) round on Jan 20, 2022, with participation from 1 investor.

What is the annual revenue of Qiagen?

Annual revenue of Qiagen is €1.97B as on Dec 31, 2023.

Where does Qiagen rank among its competitors?

Qiagen ranks 2nd amongst 235 active competitors, of which 37 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was JUMPCODE Genomics, which secured $3.46M in Aug, 2024.

Who are the top competitors of Qiagen?

Qiagen's top competitors include Neogen, Parse Biosciences and JUMPCODE Genomics. Among them, JUMPCODE Genomics secured the most recent funding round in August, 2024.

Qiagen - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider of products and reagents for molecular diagnostic assays. The company's products are used to isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. It also provides reagents for PCR, sequencing, detection solutions, automated solutions, analytics software, RNAi, epigenetics, and lab basics.

Website: www.qiagen.com/us
Social

Key Metrics

Founded Year

1984

Location

Venlo, Netherlands

Stage

Acquired

Latest Funding Round

Grant (prize money), Jan 20, 2022, $*****

Investors

Life Sciences Partners & 6 more

Ranked

2^nd among 235 active competitors

Annual Revenue

€1.97B as on Dec 31, 2023

Employee Count

5,539 as on Mar 31, 2026

Investment & Acquisitions

Genoox & 32 more

Similar Companies

Neogen & 303 more

Exit Details

Acquired by Thermo Fisher Scientific (Mar 03, 2020)

View Qiagen's full profile

Qiagen is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Qiagen NV CIN: 12036979 , Netherlands, Active	Nov 29, 1984	$2.13B (As on Dec 31, 2023)	-	-
QIAGEN INDIA PRIVATE LIMITED CIN: U74900DL2009PTC196804 , India, Active	Dec 11, 2009	$25.1M (As on Mar 31, 2025)	104 (As on Oct 31, 2024)
QIAGEN NEW ZEALAND LIMITED CIN: 8148853 , New Zealand, Active	Dec 24, 2020	-	-
QIAGEN, LLC CIN: 573145 , United States, Active	Jun 06, 2018	-	-	-
TAIBA Company s.r.o. CIN: 07749741 , Czech Republic, Active	Jan 01, 2019	-	-

Qiagen got acquired by Thermo Fisher Scientific on Mar 03, 2020. It was facilitated by J P Morgan, Wachtell, Lipton, Rosen & Katz, Morgan Stanley and 6 more.

Click here to take a look at Qiagen's acquisition in detail

Qiagen has raised funding over 13 rounds. Its first funding round was on Oct 02, 2007. Its latest funding round was a Grant (prize money) round on Jan 20, 2022 for $*****. 1 investor participated in its latest round. Qiagen has 7 institutional investors.

Here is the list of recent funding rounds of Qiagen:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 20, 2022	3004873	Grant (prize money)	2376132	9317316	3154725	4207140
Jul 01, 2021	6206621	Grant (prize money)	5371317	6106185	1730178	Europa
Mar 01, 2021	8972954	Grant (prize money)	8537091	8667788	6690294	Europa

Access funding benchmarks and valuations. Sign up today!

View details of Qiagen's funding rounds and investors

The founders of Qiagen is Metin Colpan. Metin Colpan is the CEO of Qiagen.

Here are the details of Qiagen's key team members:

Metin Colpan: Co-Founder & CEO of Qiagen.
Contact Info: 1 email address

View details of Qiagen's Founder profiles and Board Members

Qiagen's employee count trend

Qiagen has 5,539 employees as of Mar 26. Here is Qiagen's employee count trend over the years:

Uncover Qiagen's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Qiagen include Neogen, Parse Biosciences and JUMPCODE Genomics. Here is the list of Top 10 competitors of Qiagen, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Neogen 1982, Lansing (United States), Acquired	Solutions for food and animal safety, diagnostics, and genomics	$700K	Innovative Ventures, NISA	67/100
2nd	Qiagen 1984, Venlo (Netherlands), Acquired	Provider of products and reagents for molecular diagnostic assays	-	Life Sciences Partners, Quan Capital & 5 others	65/100
3rd	Parse Biosciences 2018, Seattle (United States), Series C	Developer of RNA-sequencing solution-based transcriptome kit to analyze health data	$100M	Janus Henderson Investors, Marshall Wace & 7 others	64/100
4th	JUMPCODE Genomics 2016, Carlsbad (United States), Series B	Provider of a technology for depleting unwanted nucleic acid	$38.7M	Arboretum Ventures, Baird Capital & 1 others	59/100
5th	ArcherDX 2013, Boulder (United States), Acquired	Developer of molecular cancer diagnostic products	$153M	Perceptive Advisors, PBM Capital & 8 others	58/100
6th	Devyser 2004, Stockholm (Sweden), Public	Provider of molecular diagnostic kits for cancer, hereditary diseases, and reproductive disorders	$15.5M	Swedbank Robur, Fjarde AP-fonden & 1 others	57/100
7th	Genomtec 2016, Wroclaw (Poland), Series A	Provider of handheld POC device for nucleic acid testing	$4.38M	KnowledgeHub, NRDC & 5 others	54/100
8th	Sebia 1967, Evry Courcouronnes (France), Acquired	Developer of electrophoresis-based in vitro diagnostics products	-	AlpInvest Partners, Astorg Partners & 4 others	53/100
9th	NuProbe 2016, George Town (Cayman Islands), Series B	Develops sensitive multiplex tool for QPCR	$61M	Sequoia Capital, BioTrack Capital & 14 others	51/100
10th	Fluent BioSciences 2018, Watertown (United States), Acquired	Developer of reagent for DNA analysis for genetic analysis	$19M	Samsara BioCapital, Illumina Ventures & 5 others	51/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Qiagen's competitors? Click here to see the top ones

Qiagen has made 7 investments in companies including HTG Molecular Diagnostics and Protagen. Qiagen has also acquired 26 companies including Genoox and Verogen.

Here is the list of investments & acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
May 12, 2025	Acquisition	Genoox	2012	Tel Aviv (Israel)
Jan 09, 2023	Acquisition	Verogen	2017	San Diego (United States)
May 11, 2022	Acquisition	Blirt	2008	Gdansk (Poland)